Tang Capital Management’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Tang Capital Management’s Portfolio MTCR Stock Details MTCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,250,000	Closed	-$1.9M	–	126
2022 Q4	$1.9M	Buy	4,250,000 +2,531,780	+147%	+$1.05M	0.28%	61
2022 Q3	$833K	Buy	+1,718,220	New	+$845K	0.1%	89

Other funds holding MTCR

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Tang Capital Management's MTCR Position: Q1 2023 in Review

Tang Capital Management sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 4,250,000 shares — an estimated $1.9M sold.

Tang Capital Management first reported a position in MTCR in Q3 2022 and held it in 2 quarters. The position peaked at $1.9M in Q4 2022. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.

Tang Capital Management reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Tang Capital Management sold 4,250,000 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $1.9M.
Tang Capital Management first reported a position in Metacrine, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Tang Capital Management's Metacrine, Inc. Common Stock position peaked at $1.9M in Q4 2022.
5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.

Based on Tang Capital Management's 13F filing for Q1 2023, filed 15 May 2023.